These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1511154)

  • 1. Neurofibromatosis: from gene to phenotype.
    Ponder BA
    Semin Cancer Biol; 1992 Jun; 3(3):115-20. PubMed ID: 1511154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hunt for the neurofibromatosis gene.
    Goldberg NS; Collins FS
    Arch Dermatol; 1991 Nov; 127(11):1705-7. PubMed ID: 1952978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 1.
    Legius E; Descheemaeker MJ; Fryns JP; Van den Berghe H
    Genet Couns; 1994; 5(3):225-41. PubMed ID: 7811422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
    Dilworth JT; Kraniak JM; Wojtkowiak JW; Gibbs RA; Borch RF; Tainsky MA; Reiners JJ; Mattingly RR
    Biochem Pharmacol; 2006 Nov; 72(11):1485-92. PubMed ID: 16797490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.
    Garza R; Hudson RA; McMahan CA; Walter CA; Vogel KS
    Mutat Res; 2007 Feb; 615(1-2):98-110. PubMed ID: 17208258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions.
    Lopez Correa C; Brems H; Lázaro C; Estivill X; Clementi M; Mason S; Rutkowski JL; Marynen P; Legius E
    Hum Mutat; 1999; 14(5):387-93. PubMed ID: 10533064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF1 mutation analysis using a combined heteroduplex/SSCP approach.
    Abernathy CR; Rasmussen SA; Stalker HJ; Zori R; Driscoll DJ; Williams CA; Kousseff BG; Wallace MR
    Hum Mutat; 1997; 9(6):548-54. PubMed ID: 9195229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetics of neurofibromatosis: recent progress and prospects].
    Maillet-Vioud M; Narod S; Assouline D; Sobol H; Fischer G; Robert JM; Lenoir GM
    Rev Neurol (Paris); 1991; 147(10):644-52. PubMed ID: 1763253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, pathologic, and genetic features of massive soft tissue neurofibromas in a Sicilian patient.
    Bongiorno MR; Cefalù AB; Aricò M; Averna M
    Dermatol Ther; 2008; 21 Suppl 3():S21-5. PubMed ID: 19076627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17q inversion involving the neurofibromatosis type one locus in a family with neurofibromatosis type one.
    Asamoah A; North K; Doran S; Wagstaff J; Ogle R; Collins FS; Korf BR
    Am J Med Genet; 1995 Aug; 60(4):312-6. PubMed ID: 7485267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and recurrent mutations in the neurofibromatosis type 1 (NF1) gene.
    Hudson J; Wu CL; Tassabehji M; Summers EM; Simon S; Super M; Donnai D; Thakker N
    Hum Mutat; 1997; 9(4):366-7. PubMed ID: 9101300
    [No Abstract]   [Full Text] [Related]  

  • 14. Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion.
    Ainsworth PJ; Chakraborty PK; Weksberg R
    Hum Mutat; 1997; 9(5):452-7. PubMed ID: 9143926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two independent mutations in a family with neurofibromatosis type 1 (NF1).
    Klose A; Peters H; Hoffmeyer S; Buske A; Lüder A; Hess D; Lehmann R; Nürnberg P; Tinschert S
    Am J Med Genet; 1999 Mar; 83(1):6-12. PubMed ID: 10076878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1?
    Cnossen MH; van der Est MN; Breuning MH; van Asperen CJ; Breslau-Siderius EJ; van der Ploeg AT; de Goede-Bolder A; van den Ouweland AM; Halley DJ; Niermeijer MF
    Hum Mutat; 1997; 9(5):458-64. PubMed ID: 9143927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association.
    Bahuau M; Flintoff W; Assouline B; Lyonnet S; Le Merrer M; Prieur M; Guilloud-Bataille M; Feingold N; Munnich A; Vidaud M; Vidaud D
    Am J Med Genet; 1996 Dec; 66(3):347-55. PubMed ID: 8985499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
    Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
    J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.
    Abernathy CR; Colman SD; Kousseff BG; Wallace MR
    Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mosaicism of a greater than 1.7-Mb deletion of genomic DNA involving the entire NF1 gene as verified by FISH: further evidence for a contiguous gene syndrome in 17q11.2.
    Streubel B; Latta E; Kehrer-Sawatzki H; Hoffmann GF; Fonatsch C; Rehder H
    Am J Med Genet; 1999 Nov; 87(1):12-6. PubMed ID: 10528240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.